Schneiderman said Quincy Bioscience based its claims primarily on a single study that failed to show a statistically significant improvement in memory.
News
- Lawsuit disputes claims of popular memory-loss supplement
- There's something missing from one of the largest healthcare investor meetings of the year
In pharma and biotech, the number of women in leadership roles is still fairly low. In September 2015, GSK announced that Emma Walmsley would ...
- The biggest healthcare investor conference is happening next week — here are the 5 things we ...
When they see something that's cool, they all jump on it and say I gotta have it," Doug MacDougall, managing partner at MacDougall Biomedical ...
- Tight labor market hinders search for skilled workers
An encouraging sign, Abair said, was a 57 percent increase in the number of graduates with biotechnology degrees from four-year institutions in ...
- Mending broken bones is key for Louisville startup
Unbeknownst to Paul, her bad break became the perfect candidate for a new bone graft product created by Vivorte, a Louisville biomedical startup.